SHANGHAI , Jan. 11, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, announced that U.S. Food and Drug Administration (FDA) has recently granted ...
BERLIN , Jan. 10, 2024 /PRNewswire/ -- Ariceum Therapeutics, a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announces it has submitted an ...
SHANGHAI , Jan. 8, 2024 /PRNewswire/ -- On January 9, 2024 (Beijing Time) , Abbisko Therapeutics (HKEX code: 02256) announced that its investigational innovative CSF-1R inhibitor pimicotinib(ABSK021) has been granted orphan drug ...
HOLON, Israel , Jan. 8, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that Compugen is entitled to receive a ...
HONG KONG , Jan. 5, 2024 /PRNewswire/ -- Akeso (9926.HK) announced the China National Medical Products Administration (NMPA) has accepted the supplemental new drug application (sNDA) of cadonilimab (???®, PD-1/CTLA-4 bispecific ...
SHANGHAI , Jan. 4, 2024 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National ...
Financing led by Novo Holdings, OrbiMed, and F-Prime Capital, with participation by new and current investors Proceeds to advance CUSP06, the company's antibody drug conjugate (ADC) targeting CDH6, to clinical ...
ROCKVILLE, Md. and SUZHOU, China , Dec. 27, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the ...
WUXI, China , Dec. 20, 2023 /PRNewswire/ -- BioCity Biopharma today announced dosing of the first patient in a Phase Ib/II clinical trial of its anti-TIM-3 monoclonal antibody (mAb) BC3402 in combination with IMFINZI (durvalumab) for the ...
HANGZHOU, China , Dec. 20, 2023 /PRNewswire/ -- Recently, a CAR-macrophage therapy product (CAR-M) SY001 from CellOrigin Biotechnology ( Hangzhou ) Co., Ltd. was dosed to the first patient in a hospital in China . "A single center, ...
Ex-cigarette smokers who use e-cigarettes or vaping devices may face a higher risk of lung cancer compared to those who don't vape ( ). “This is the first large ...
Immunotherapy, which aims to harness the immune system to combat cancer, has proven effective for about 20% of cancer patients. Notable progress has been made, particularly in treating lung cancer and melanoma . Inspired by the significant potential ...
Researchers at The Australian National University (ANU) have developed a new AI tool DEPLOY that quickly and accurately classifies brain tumors. Dr. Danh-Tai Hoang emphasizes that precise diagnosis and categorization of tumors are crucial for ...
Breast cancer remains the predominant cancer among women globally, with escalating rates prompting a pressing quest for novel modifiable risk factors. Recent findings propose a correlation between increased childhood adiposity and decreased breast ...
Researchers have unveiled a fresh understanding of the genetic pathway involved in childhood cancer , providing optimism for personalized treatments. Their development of a stem cell model aims to probe the roots of neuroblastoma, a cancer ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers